Skip to content
Screener

Income Tax at other companies

AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$3.54M-119%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$23K
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$40K-9.1%
Absci Corporation logo
Absci CorporationABSI
$18K+550%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$18K+12.5%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$79K-4.8%

Other financials

Income statement

See full
Revenue$124.4M+2.0%
Gross profit$86.3M+28.3%
Operating income$52.4M+22.5%
Net income$37.8M+10.5%
EPS (diluted)$0.16+14.3%

Balance sheet

See full
Cash & equivalents$136.0M+50.7%
Total debt$203.9M+1,855%
Total equity$408.2M+2.5%
Total assets$684.2M+22.5%

Cash flow

See full
Operating cash flow$29.5M+39.7%
CapEx$2.3M-6.9%
Free cash flow$27.3M+45.8%

Valuation

See full
Market cap$2.25B-49.1%
Enterprise value$2.32B-46.6%
P/E13.3×-7.9×
P/S4.4×-4.9×

Profitability

See full
Gross margin64.7%+11.7pp
Operating margin43.8%+11.0pp
Net margin33%-11.1pp
FCF margin22.7%+8.9pp

Returns & leverage

See full
Return on equity41.9%-29.3pp
Debt / equity0.5×+0.5×
Current ratio+1.6×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:16 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001140361-26-031445
Line itemThree Months ended June 30, 2026Three Months ended June 30, 2025Six Months ended June 30, 2026Six Months ended June 30, 2025
Other expense(22)(108)(161)(172)
Other income (expense), net(2,208)(2,701)(3,354)(4,132)
INCOME BEFORE INCOME TAXES50,23740,097107,36573,546
Provision for income taxes12,4155,87824,21512,424
NET INCOME$$37,822$34,219$83,15061,122
BASIC EARNINGS PER COMMON SHARE$$0.17$0.14$0.360.26
DILUTED EARNINGS PER COMMON SHARE$$0.16$0.14$0.350.25
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:

Item 1. Financial Statements.

FAQ

What is ADMA Biologics's income tax?
ADMA Biologics (ADMA) reported income tax of $12.42M in Q2 2026.
How has ADMA Biologics's income tax changed year-over-year?
ADMA Biologics's income tax increased by 111.2% year-over-year, from $5.88M to $12.42M.
What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.

Ask your AI about ADMA Biologics's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude